P53 expression in patients with advanced urothelial cancer of the urinary bladder
Carcinoma in Situ
Neoplasm Recurrence, Local
Tumor Suppressor Protein p53
Urinary Bladder Neoplasms
While assessing p53 expression has limited utility in patients with lymph node-positive UCB, it marginally improves prognostication in patients with advanced non-metastatic UCB. Integration of p53 into a panel of biomarkers might be necessary to capture a more accurate picture of the biological potential of advanced UCB.